Expression of nodal signalling components in cycling human endometrium and in endometrial cancer

Reproductive Biology and Endocrinology

Volumn 7, Issue , 2009, Pages

  Papageorgiou, Irene ^a,b   Nicholls, Peter K ^a,b   Wang, Fang ^a   Lackmann, Martin ^b   Makanji, Yogeshwar ^a,b   Salamonsen, Lois A ^a   Robertson, David M ^a   Harrison, Craig A ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CRIPTO; LEFTY A; ONCOPROTEIN; PROTEIN NODAL; UNCLASSIFIED DRUG; EPIDERMAL GROWTH FACTOR; LEFT RIGHT DETERMINATION FACTOR; MEMBRANE PROTEIN; NODAL PROTEIN, HUMAN; TDGF1 PROTEIN, HUMAN; TUMOR PROTEIN;

ARTICLE; CANCER GRADING; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM CANCER; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; MENSTRUAL CYCLE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; ADULT; BODY FLUID; CARCINOMA; ENDOMETRIUM TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; SECRETION; UTERUS;

ADULT; BODY FLUIDS; CARCINOMA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEFT-RIGHT DETERMINATION FACTORS; MEMBRANE GLYCOPROTEINS; MENSTRUAL CYCLE; NEOPLASM PROTEINS; NODAL PROTEIN; SIGNAL TRANSDUCTION; UTERUS;

EID: 71149083121     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-7-122     Document Type: Article

References (42)

1. Shen MM. Nodal signaling: developmental roles and regulation. Development 2007, 134(6):1023-1034. 10.1242/dev.000166, 17287255.
2. Harrison CA, Gray PC, Koerber SC, Fischer W, Vale W. Identification of a functional binding site for activin on the type I receptor ALK4. J Biol Chem 2003, 278(23):21129-21135. 10.1074/jbc.M302015200, 12665502.
3. Kelber JA, Shani G, Booker EC, Vale WW, Gray PC. Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal. J Biol Chem 2008, 283(8):4490-4500. 10.1074/jbc.M704960200, 18089557.
4. Gray PC, Harrison CA, Vale W. Cripto forms a complex with activin and type II activin receptors and can block activin signaling. Proc Natl Acad Sci USA 2003, 100(9):5193-5198. 154321, 12682303, 10.1073/pnas.0531290100.
5. Cheng SK, Olale F, Brivanlou AH, Schier AF. Lefty blocks a subset of TGFbeta signals by antagonizing EGF-CFC coreceptors. PLoS Biol 2004, 2(2):E30. 340941, 14966532, 10.1371/journal.pbio.0020030.
6. Brennan J, Lu CC, Norris DP, Rodriguez TA, Beddington RS, Robertson EJ. Nodal signalling in the epiblast patterns the early mouse embryo. Nature 2001, 411(6840):965-969. 10.1038/35082103, 11418863.
7. Schier AF, Shen MM. Nodal signalling in vertebrate development. Nature 2000, 403(6768):385-389. 10.1038/35000126, 10667782.
8. Kenney NJ, Adkins HB, Sanicola M. Nodal and Cripto-1: embryonic pattern formation genes involved in mammary gland development and tumorigenesis. J Mammary Gland Biol Neoplasia 2004, 9(2):133-144. 10.1023/B:JOMG.0000037158.91940.1c, 15300009.
9. Bianco C, Adkins HB, Wechselberger C, Seno M, Normanno N, De Luca A, Sun Y, Khan N, Kenney N, Ebert A, Williams KP, Sanicola M, Salomon DS. Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells. Mol Cell Biol 2002, 22(8):2586-2597. 133714, 11909953, 10.1128/MCB.22.8.2586-2597.2002.
10. Zhang YQ, Sterling L, Stotland A, Hua H, Kritzik M, Sarvetnick N. Nodal and lefty signaling regulates the growth of pancreatic cells. Dev Dyn 2008, 237(5):1255-1267. 10.1002/dvdy.21527, 18393305.
11. Postovit LM, Margaryan NV, Seftor EA, Hendrix MJ. Role of nodal signaling and the microenvironment underlying melanoma plasticity. Pigment Cell Melanoma Res 2008, 21(3):348-357. 10.1111/j.1755-148X.2008.00463.x, 18444961.
12. Topczewska JM, Postovit LM, Margaryan NV, Sam A, Hess AR, Wheaton WW, Nickoloff BJ, Topczewski J, Hendrix MJ. Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nat Med 2006, 12(8):925-932. 10.1038/nm1448, 16892036.
13. Tabibzadeh S, Lessey B, Satyaswaroop PG. Temporal and site-specific expression of transforming growth factor-beta4 in human endometrium. Mol Hum Reprod 1998, 4(6):595-602. 10.1093/molehr/4.6.595, 9665343.
14. Tabibzadeh S, Mason JM, Shea W, Cai Y, Murray MJ, Lessey B. Dysregulated expression of ebaf, a novel molecular defect in the endometria of patients with infertility. J Clin Endocrinol Metab 2000, 85(7):2526-2536. 10.1210/jc.85.7.2526, 10902804.
15. Cornet PB, Galant C, Eeckhout Y, Courtoy PJ, Marbaix E, Henriet P. Regulation of matrix metalloproteinase-9/gelatinase B expression and activation by ovarian steroids and LEFTY-A/endometrial bleeding-associated factor in the human endometrium. J Clin Endocrinol Metab 2005, 90(2):1001-1011. 10.1210/jc.2004-1277, 15536155.
16. Tang M, Taylor HS, Tabibzadeh S. In vivo gene transfer of lefty leads to implantation failure in mice. Hum Reprod 2005, 20(7):1772-1778. 10.1093/humrep/deh849, 15790608.
17. Chen C, Shen MM. Two modes by which Lefty proteins inhibit nodal signaling. Curr Biol 2004, 14(7):618-624. 10.1016/j.cub.2004.02.042, 15062104.
18. Torres PB, Florio P, Galleri L, Reis FM, Borges LE, Petraglia F. Activin A, activin receptor type II, nodal, and cripto mRNA are expressed by eutopic and ectopic endometrium in women with ovarian endometriosis. Reprod Sci 2009, 16(8):727-733. 10.1177/1933719109334967, 19386982.
19. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril 1950, 1:3-25.
20. Paiva P, Van Damme MP, Tellbach M, Jones RL, Jobling T, Salamonsen LA. Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer. Gynecol Oncol 2005, 98(2):193-202. 10.1016/j.ygyno.2005.02.031, 15936804.
21. Jones RL, Salamonsen LA, Zhao YC, Ethier JF, Drummond AE, Findlay JK. Expression of activin receptors, follistatin and betaglycan by human endometrial stromal cells; consistent with a role for activins during decidualization. Mol Hum Reprod 2002, 8(4):363-374. 10.1093/molehr/8.4.363, 11912285.
22. Besser D. Expression of nodal, lefty-a, and lefty-B in undifferentiated human embryonic stem cells requires activation of Smad2/3. J Biol Chem 2004, 279(43):45076-45084. 10.1074/jbc.M404979200, 15308665.
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25(4):402-408. 10.1006/meth.2001.1262, 11846609.
24. Lachance C, Bailey JL, Leclerc P. Expression of Hsp60 and Grp78 in the human endometrium and oviduct, and their effect on sperm functions. Hum Reprod 2007, 22(10):2606-2614. 10.1093/humrep/dem242, 17670764.
25. Tang M, Mikhailik A, Pauli I, Giudice LC, Fazelabas AT, Tulac S, Carson DD, Kaufman DG, Barbier C, Creemers JW, Tabibzadeh S. Decidual differentiation of stromal cells promotes Proprotein Convertase 5/6 expression and lefty processing. Endocrinology 2005, 146(12):5313-5320. 10.1210/en.2005-0684, 16141390.
26. Hannan NJ, Stoikos CJ, Stephens AN, Salamonsen LA. Depletion of high-abundance serum proteins from human uterine lavages enhances detection of lower-abundance proteins. J Proteome Res 2009, 8(2):1099-1103. 10.1021/pr800811y, 19113883.
27. Stoikos CJ, Harrison CA, Salamonsen LA, Dimitriadis E. A distinct cohort of the TGFbeta superfamily members expressed in human endometrium regulate decidualization. Hum Reprod 2008, 23(6):1447-1456. 2387221, 18434375, 10.1093/humrep/den110.
28. Kelber JA, Panopoulos AD, Shani G, Booker EC, Belmonte JC, Vale WW, Gray PC. Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways. Oncogene 2009, 28(24):2324-2336. 2749668, 19421146, 10.1038/onc.2009.97.
29. Shani G, Fischer WH, Justice NJ, Kelber JA, Vale W, Gray PC. GRP78 and Cripto form a complex at the cell surface and collaborate to inhibit transforming growth factor beta signaling and enhance cell growth. Mol Cell Biol 2008, 28(2):666-677. 2223411, 17991893, 10.1128/MCB.01716-07.
30. Constam DB, Robertson EJ. Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases. J Cell Biol 1999, 144(1):139-149. 2148113, 9885250, 10.1083/jcb.144.1.139.
31. Gargett CE, Chan RW, Schwab KE. Hormone and growth factor signaling in endometrial renewal: role of stem/progenitor cells. Mol Cell Endocrinol 2008, 288(1-2):22-29. 10.1016/j.mce.2008.02.026, 18403104.
32. Maruyama T, Yoshimura Y. Molecular and cellular mechanisms for differentiation and regeneration of the uterine endometrium. Endocr J 2008, 55(5):795-810. 10.1507/endocrj.K08E-067, 18580040.
33. Salamonsen LA. Tissue injury and repair in the female human reproductive tract. Reproduction 2003, 125(3):301-311. 10.1530/rep.0.1250301, 12611594.
34. Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001, 29(2):117-129. 10.1038/ng1001-117, 11586292.
35. Gordon KJ, Blobe GC. Role of transforming growth factor-beta superfamily signaling pathways in human disease. Biochim Biophys Acta 2008, 1782(4):197-228.
36. Young GD, Murphy-Ullrich JE. Molecular interactions that confer latency to transforming growth factor-beta. J Biol Chem 2004, 279(36):38032-38039. 10.1074/jbc.M405658200, 15208302.
37. Kaitu'u-Lino TJ, Phillips DJ, Morison NB, Salamonsen LA. A new role for activin in endometrial repair after menses. Endocrinology 2009, 150(4):1904-1911. 10.1210/en.2008-0738, 19022896.
38. He ZY, Liu HC, Mele CA, Barmat L, Veeck LL, Davis O, Rosenwaks Z. Expression of inhibin/activin subunits and their receptors and binding proteins in human preimplantation embryos. J Assist Reprod Genet 1999, 16(2):73-80. 10.1023/A:1022564722353, 10079409.
39. Ni X, Luo S, Minegishi T, Peng C. Activin A in JEG-3 cells: potential role as an autocrine regulator of steroidogenesis in humans. Biol Reprod 2000, 62(5):1224-1230. 10.1095/biolreprod62.5.1224, 10775170.
40. Caniggia I, Lye SJ, Cross JC. Activin is a local regulator of human cytotrophoblast cell differentiation. Endocrinology 1997, 138(9):3976-3986. 10.1210/en.138.9.3976, 9275089.
41. Strizzi L, Bianco C, Normanno N, Salomon D. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis. Oncogene 2005, 24(37):5731-5741. 10.1038/sj.onc.1208918, 16123806.
42. Ayhan A, Tuncer ZS, Ruacan S, Yasui W, Tahara E. Abnormal expression of cripto and p53 protein in endometrial carcinoma and its precursor lesions. Eur J Gynaecol Oncol 1998, 19(3):316-318.